Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Philadelphia chromosome-positive Chronic Myeloid Leukemia (Ph+ CML) and Ph+ Acute Lymphoblastic Leukemia (ALL).
HER2-positive or HER2-low metastatic Breast Cancer, HER2-mutant Non-Small Cell Lung Cancer, and Gastric Adenocarcinoma.
HER2-positive or HER2-low metastatic Breast Cancer, HER2-mutant Non-Small Cell Lung Cancer, and Gastric Adenocarcinoma.
Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Approved for use in oncology care according to FDA-approved indications.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
Advanced Prostate Cancer and Premenopausal Hormone-Receptor Positive Breast Cancer.
Approved for use in oncology care according to FDA-approved indications.